Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin Alfa and hpHMG in Poor Ovarian Responders (Long GnRH Agonist Protocol)
NCT01732094Phase 2Completed
- Sponsor
- UZ Brussel
- Start
- Jul 2012
- Primary completion
- May 2013
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of corifollitropin alfa in poor ovarian response (POR) and infertility, sponsored by UZ Brussel. Primary endpoint: Ongoing pregnancy rate. Started Jul 2012; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
poor ovarian response (POR)infertility
Beyond the preview
Go deeper on NCT01732094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01732094.